Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii

There are currently no defined optimal therapies available for multidrug-resistant (MDR) Acinetobacter baumannii infections. We evaluated the efficacy of rifampin, imipenem, sulbactam, colistin, and their combinations against MDR A. baumannii in experimental pneumonia and meningitis models. The bact...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Pachón-Ibáñez, María E., Docobo-Pérez, Fernando, López-Rojas, Rafael, Domínguez-Herrera, Juan, Jiménez-Mejias, Manuel E., García-Curiel, Andrés, Pichardo, Cristina, Jiménez, Luis, Pachón, Jerónimo
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 2010
Soggetti:
Experimental Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2825983/
https://ncbi.nlm.nih.gov/pubmed/20047914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00367-09
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi